LifeSci Venture Partners
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio1 active
4Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Veradermics
29Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Disc Medicine | Biotech | Active | — | — |
| Veradermics | Biotech | Public | May 15, 2026 | $269.3M |
| Vigil Neuroscience | Biotech | Acquired | Aug 29, 2022 | $195.0M |
| Acelyrin | Biotech | Acquired | — | — |
| Day One Biopharmaceuticals | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#81
Portfolio exits#49
Raises, 12 months#22
Co-investors#62
Co-investors
- Atlas VentureVenture capital3 shared
- Longitude CapitalVenture capital3 shared
- Aisling CapitalVenture capital2 shared
- Avoro Capital AdvisorsVenture capital2 shared
- Perceptive AdvisorsVenture capital2 shared
- PJCVenture capital2 shared
- SR OneVenture capital2 shared
- Altitude Life Science VenturesVenture capital1 shared
- Apple Tree PartnersVenture capital1 shared
- BiogenVenture capital1 shared
Sectors
- Biotech5
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.